Case Studies Case Studies

View by Disease Area:   Cancer | CNS
Profiling New Drug Targets for Alzheimer’s Disease
SysQuant® Global Phosphoproteomics

Read More

Stacking the Odds in Alzheimer’s Disease Drug Development
SysQuant® Global Phosphoproteomics

Read More

Unravelling the Mechanism of Action of Combined Targets in Melanoma
SysQuant® Global Phosphoproteomics

Read More

Translating Experimental Model Data to Human Disease
SysQuant® Global Phosphoproteomics

Read More

The Hunt for Early Diagnostic Biomarkers of AD
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Read More

Clusterin Glycosylation – A Prognostic AD Plasma Biomarker
SRM Assay Development

Read More

Stratification Biomarkers of MCI Conversion
TMT®MS3 Quantitative Proteomics

Read More

Highlighting Pharmacodynamic Biomarkers of AD
SysQuant® Global Phosphoproteomics
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Read More

Targeting Markers of Neurodegeneration in CSF
TMT®SRM Assay Development

Read More

Introducing Proteomics to Allergy Testing
TMT®MS2 Broadest Coverage Workflow
TMT®SRM Assay Development

Read More

Characterization of Tau phosphorylation in Preclinical Models of AD
SRM Assay Development

Read More

Identifying Biomarkers of Aspirin Resistance in Cardiovascular Disease
SRM Assay Development

Read More

Stratification of Breast Tumors Based on ER, PR and HER2 Expression and Activity
SRM Assay Development

Read More

Putting Personalized Medicine to Work in Pancreatic Cancer
SysQuant® Global Phosphoproteomics

Read More

Quantification of Tau and Other Low Abundance Brain Markers in CSF
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Read More

Differentiating Endophenotypes of ALS
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Read More

Differentiating Fast and Slow Progressing ALS
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics

Read More

Profiling Cancer Plasma Biomarkers
TMT®MS3 Quantitative Proteomics

Read More

Differentiating ALS Endophenotypes Using PBMC Biomarkers
TMT®MS3 Quantitative Proteomics

Read More

PBMCs – An Alternative Source of Biomarkers
TMT®MS2 Broadest Coverage Workflow

Read More

Profiling Liver Tumors to Optimize Drug Selection
SysQuant® Global Phosphoproteomics

Read More

Profiling cMet Pathway Inhibition in Prostate Cancer
TMT®MS2 Broadest Coverage Workflow
TMT®SRM Assay Development

Read More

Proteomic Screening for Neurotoxic Effects of Pesticides and Environmental Pollutants
TMTcalibrator™ Tissue-Enhanced Fluid Proteomics
TMT®MS3 Quantitative Proteomics

Read More